ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

Clinical trial NCT03130777 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03130777
Sponsor: Edwards Lifesciences
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pulmonary Disease Transcatheter Pulmonary Valve Replacement (TPVR)Tetralogy of Fallot Congenital Heart Disease Pulmonary Regurgitation

Start date: 2017-08-22
Primary completion: 2022-07-14
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.